Robert Olstein's IART Position Overview
Robert Olstein (via Olstein Capital Management, L.P.) currently holds 123,000 shares of Integra LifeSciences Holdings Corporation (IART) worth $1.53 M, representing 0.31% of the portfolio. First purchased in 2014-Q1, this long-term strategic position has been held for 34 quarters.
Based on 13F filings, Robert Olstein has maintained a strategic position in IART, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2024, adding 42,000 shares. Largest reduction occurred in Q3 2015, reducing 116,000 shares.
Analysis based on 13F filings available since 2013 Q2
Robert Olstein's Integra LifeSciences Holdings Corporation (IART) Holding Value Over Time
Track share changes against reported price movement
Quarterly Integra LifeSciences Holdings Corporation (IART) Trades by Robert Olstein
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | -16,000 | Reduce 11.51% | 123,000 | $12.42 |
| Q3 2025 | +4,000 | Add 2.96% | 139,000 | $14.33 |
| Q2 2025 | +37,000 | Add 37.76% | 135,000 | $12.27 |
| Q1 2025 | -35,000 | Reduce 26.32% | 98,000 | $21.99 |
| Q4 2024 | -22,000 | Reduce 14.19% | 133,000 | $22.68 |
| Q3 2024 | +42,000 | Add 37.17% | 155,000 | $18.17 |
| Q2 2024 | +13,000 | Add 13.00% | 113,000 | $29.14 |
| Q1 2024 | +26,000 | Add 35.14% | 100,000 | $35.45 |
| Q4 2023 | +3,000 | Add 4.23% | 74,000 | $43.55 |
| Q3 2023 | +2,000 | Add 2.90% | 71,000 | $38.18 |
| Q2 2023 | +24,000 | Add 53.33% | 69,000 | $41.13 |
| Q1 2023 | -1,000 | Reduce 2.17% | 45,000 | $57.40 |
| Q3 2022 | +1,000 | Add 2.22% | 46,000 | $42.37 |
| Q2 2022 | +3,000 | Add 7.14% | 45,000 | $54.02 |
| Q1 2022 | -3,000 | Reduce 6.67% | 42,000 | $64.26 |
| Q4 2021 | +4,000 | Add 9.76% | 45,000 | $67.00 |
| Q3 2021 | -5,000 | Reduce 10.87% | 41,000 | $68.49 |
| Q4 2020 | +3,000 | Add 6.98% | 46,000 | $64.91 |
| Q3 2020 | +7,000 | Add 19.44% | 43,000 | $47.21 |
| Q2 2020 | +4,290 | Add 13.53% | 36,000 | $47.00 |
| Q1 2020 | +10,710 | Add 51.00% | 31,710 | $44.65 |
| Q4 2019 | +12,000 | Add 133.33% | 21,000 | $58.29 |
| Q3 2019 | +1,000 | Add 12.50% | 9,000 | $60.11 |
| Q2 2019 | +8,000 | New Buy | 8,000 | $55.88 |
| Q3 2015 | -116,000 | Sold Out | 0 | $0.00 |
| Q2 2015 | -4,000 | Reduce 3.33% | 116,000 | $33.68 |
| Q1 2015 | +6,000 | Add 5.26% | 120,000 | $30.82 |
| Q4 2014 | +4,000 | Add 3.64% | 114,000 | $27.11 |
| Q2 2014 | +12,000 | Add 12.24% | 110,000 | $23.53 |
| Q1 2014 | +98,000 | New Buy | 98,000 | $23.00 |
Robert Olstein's Integra LifeSciences Holdings Corporation Investment FAQs
Robert Olstein first purchased Integra LifeSciences Holdings Corporation (IART) in Q1 2014, acquiring 98,000 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Robert Olstein has held Integra LifeSciences Holdings Corporation (IART) for 34 quarters since Q1 2014.
Robert Olstein's largest addition to Integra LifeSciences Holdings Corporation (IART) was in Q1 2014, adding 98,000 shares worth $2.25 M.
According to the latest 13F filing for Q4 2025, Robert Olstein's firm, Olstein Capital Management, L.P., owns 123,000 shares of Integra LifeSciences Holdings Corporation (IART), valued at approximately $1.53 M.
As of the Q4 2025 filing, Integra LifeSciences Holdings Corporation (IART) represents approximately 0.31% of Robert Olstein's publicly disclosed stock portfolio, making it one of their key holdings.
Robert Olstein's peak holding in Integra LifeSciences Holdings Corporation (IART) was 155,000 shares, as reported at the end of Q3 2024.